eXmoor Pharma is a specialised contract development and manufacturing organisation (CDMO) focusing on cell and gene therapies. With over 20 years of consultancy experience, the company accelerates novel therapies from discovery to patient delivery.

Based in Bristol, UK, eXmoor provides comprehensive services throughout the development journey, including process development, scale-up, GMP manufacture, fill and finish, and QP release. Their state-of-the-art facility spans 65,000 square feet and is equipped with clean rooms and a dedicated fill finish suite for viral vectors, autologous and allogenic cell therapies, and RNA technologies.

Key Products and Services

• GMP-compliant manufacturing and process development
• Viral vector production
• Cell therapy and RNA technology services
• Fill and finish capabilities
• Quality assurance and QP release
• Facility design and consultancy for CGT

With a track record of over 500 projects and a client base that includes leading biopharma companies, eXmoor continues to drive innovation and enhance the success of gene and cell therapy programmes globally.